Insider Trading History of Quinlan Paul T

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Quinlan Paul T since 2012. This trader's CIK number is 1333277. At the time of last reporting, Quinlan Paul T was the General Counsel of Cymabay Therapeutics, Inc.. (stock ticker symbol CBAY). Also see all insider trading activities at Cymabay Therapeutics, Inc..

Note that in the past Quinlan Paul T also reported insider trading activities as an insider of the following companies:

Insider Activities at Cymabay Therapeutics, Inc. (CBAY)
Insider Activities at Solazyme Inc (SZYM)

Yearly summary of insider trading at Cymabay Therapeutics, Inc. (CBAY) by Quinlan Paul T

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2024	CBAY	0	$0	5,000	$117,899	46,824	$344,691
2023	CBAY	0	$0	88,000	$1,380,332	88,000	$258,720

Yearly summary of insider trading at Solazyme Inc (TVIA) by Quinlan Paul T

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2017	TVIA	0	$0	25,000	$20,225	0	$0
2016	TVIA	0	$0	20,934	$48,197	0	$0
2015	TVIA	0	$0	12,811	$35,820	0	$0
2014	TVIA	0	$0	72,426	$758,330	42,000	$98,700
2013	TVIA	0	$0	51,739	$528,476	27,000	$63,450
2012	TVIA	0	$0	31,500	$380,063	29,000	$68,150

Insider trading activities at 2 companies by Quinlan Paul T:

1. Cymabay Therapeutics, Inc. (CBAY)

2. Solazyme Inc (TVIA)

Table 1. Insider trading of Cymabay Therapeutics, Inc. (CBAY) by Quinlan Paul T

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2024-03-13	CBAY	Option Ex	41,824	7.89	329,991
2024-01-16	CBAY	Sale	5,000	23.58	117,899
2024-01-16	CBAY	Option Ex	5,000	2.94	14,700
2023-12-15	CBAY	Sale	5,000	21.98	109,905
2023-12-15	CBAY	Option Ex	5,000	2.94	14,700
2023-11-15	CBAY	Option Ex	5,000	2.94	14,700
2023-11-15	CBAY	Sale	5,000	17.38	86,890
2023-10-16	CBAY	Option Ex	5,000	2.94	14,700
2023-10-16	CBAY	Sale	5,000	13.76	68,800
2023-09-15	CBAY	Option Ex	53,000	2.94	155,820
2023-09-15	CBAY	Sale	53,000	16.87	894,057
2023-08-15	CBAY	Option Ex	5,000	2.94	14,700
2023-08-15	CBAY	Sale	5,000	11.91	59,550
2023-07-14	CBAY	Sale	5,000	11.81	59,050
2023-07-14	CBAY	Option Ex	5,000	2.94	14,700
2023-06-30	CBAY	Option Ex	5,000	2.94	14,700
2023-06-30	CBAY	Sale	5,000	10.05	50,250
2023-05-15	CBAY	Option Ex	5,000	2.94	14,700
2023-05-15	CBAY	Sale	5,000	10.37	51,830

Table 2. Insider trading of Solazyme Inc (TVIA) by Quinlan Paul T

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2017-03-09	TVIA	Sale	25,000	.81	20,225
2016-10-14	TVIA	Sale	10,000	2.55	25,530
2016-09-16	TVIA	Sale	3,124	2.60	8,128
2016-09-13	TVIA	Sale	1,562	2.74	4,273
2016-03-10	SZYM	Sale	4,686	1.64	7,666
2016-03-08	SZYM	Sale	1,562	1.67	2,600
2015-09-15	SZYM	Sale	1,562	3.08	4,814
2015-09-17	SZYM	Sale	1,562	3.14	4,910
2015-03-09	SZYM	Sale	9,687	2.69	26,096
2014-09-09	SZYM	Sale	16,562	8.53	141,240
2014-08-15	SZYM	Sale	2,500	9.13	22,832
2014-08-19	SZYM	Sale	6,000	9.55	57,282
2014-08-19	SZYM	Option Ex	6,000	2.35	14,100
2014-07-21	SZYM	Sale	6,000	9.80	58,775
2014-07-21	SZYM	Option Ex	6,000	2.35	14,100
2014-06-19	SZYM	Option Ex	6,000	2.35	14,100
2014-06-19	SZYM	Sale	6,000	11.99	71,964
2014-05-19	SZYM	Sale	6,000	9.20	55,218
2014-05-19	SZYM	Option Ex	6,000	2.35	14,100
2014-04-21	SZYM	Option Ex	6,000	2.35	14,100
2014-04-21	SZYM	Sale	6,000	11.33	67,992
2014-03-19	SZYM	Option Ex	6,000	2.35	14,100
2014-03-19	SZYM	Sale	6,000	14.39	86,358
2014-03-04	SZYM	Sale	3,125	12.21	38,146
2014-02-24	SZYM	Sale	8,239	11.61	95,679
2014-02-24	SZYM	Option Ex	6,000	2.35	14,100
2014-01-21	SZYM	Sale	6,000	10.47	62,844
2013-12-19	SZYM	Sale	6,000	9.40	56,406
2013-11-19	SZYM	Sale	6,000	8.41	50,460
2013-10-21	SZYM	Sale	6,000	11.47	68,820
2013-09-19	SZYM	Sale	6,000	10.73	64,368
2013-08-16	SZYM	Sale	739	11.89	8,786
2013-06-19	SZYM	Sale	3,000	12.04	36,129
2013-06-19	SZYM	Option Ex	3,000	2.35	7,050
2013-05-20	SZYM	Sale	3,000	11.17	33,507
2013-05-20	SZYM	Option Ex	3,000	2.35	7,050
2013-05-10	SZYM	Option Ex	21,000	2.35	49,350
2013-05-10	SZYM	Sale	21,000	10.00	210,000
2012-10-12	SZYM	Option Ex	2,000	2.35	4,700
2012-10-12	SZYM	Sale	2,000	10.24	20,488
2012-09-19	SZYM	Option Ex	3,000	2.35	7,050
2012-09-19	SZYM	Sale	3,000	11.39	34,173
2012-09-12	SZYM	Option Ex	2,000	2.35	4,700
2012-09-12	SZYM	Sale	2,000	11.44	22,870
2012-08-20	SZYM	Option Ex	3,000	2.35	7,050
2012-08-20	SZYM	Sale	3,000	13.17	39,504
2012-08-13	SZYM	Option Ex	2,000	2.35	4,700
2012-08-13	SZYM	Sale	2,000	11.89	23,774
2012-07-19	SZYM	Option Ex	3,000	2.35	7,050
2012-07-19	SZYM	Sale	3,000	13.51	40,515
2012-07-12	SZYM	Option Ex	2,000	2.35	4,700
2012-07-12	SZYM	Sale	2,000	11.42	22,842
2012-06-12	SZYM	Option Ex	2,000	2.35	4,700
2012-06-12	SZYM	Sale	2,000	12.23	24,452
2012-05-14	SZYM	Sale	2,000	10.06	20,126
2012-05-14	SZYM	Option Ex	2,000	2.35	4,700
2012-04-12	SZYM	Option Ex	2,000	2.35	4,700
2012-04-12	SZYM	Sale	2,000	12.81	25,626
2012-03-12	SZYM	Option Ex	2,000	2.35	4,700
2012-03-12	SZYM	Sale	2,000	13.97	27,940
2012-03-02	SZYM	Sale	2,500	13.13	32,835
2012-02-13	SZYM	Option Ex	2,000	2.35	4,700
2012-02-13	SZYM	Sale	2,000	11.30	22,592
2012-01-12	SZYM	Option Ex	2,000	2.35	4,700
2012-01-12	SZYM	Sale	2,000	11.16	22,326

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Quinlan Paul T (General Counsel of Cymabay Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month